Agilent Technologies, Inc. (A) vs AbbVie Inc. (ABBV): Which Is the Better Buy in 2026?
As of 2026-08-03, A is overvalued at $138, with a DCF intrinsic value of $101 and a margin of safety of -36%. ABBV is overvalued at $251, with an intrinsic value of $178 and a margin of safety of -41%. Of the two, A has the wider margin of safety.
Rewards
- ★Agilent Technologies, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
- ★Agilent Technologies, Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
- ★Altman Z-Score of 5.15 indicates very low bankruptcy risk — the company is firmly in the safe zone.
- ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
- ★Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
- ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
Risks
- ⚠Each dollar of retained earnings has produced only $0.08 of earning power — shareholders may have been better served by dividends.
- ⚠FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
- ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
- ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
Key Valuation Metrics
Learn more →Historical Fundamentals
Learn more →Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
$1 Retained Earnings Test
Learn more →> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →Reverse DCF — Market-Implied Growth
Learn more →What growth rate is the market pricing in at $138?
The market implies +13.8% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +18.4%, reflecting heavy growth investment.
Requires positive FCF to compute implied growth rate.
Economic Moat Score
Learn more →Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.
Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.
Forensic Accounting
Learn more →M-Score Trend
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →"Market is pricing this stock without strong emotion in either direction"
"Market is optimistic — be cautious and ensure you have a margin of safety"
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
Frequently Asked Questions: A vs ABBV
Is Agilent Technologies, Inc. or AbbVie Inc. more undervalued in 2026?▼
Based on our discounted cash flow model, A trades at a -36.4% margin of safety (intrinsic value $101 vs. price $138), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).
Which stock has a wider economic moat, Agilent Technologies, Inc. or AbbVie Inc.?▼
ABBV scores 82/100 (Wide moat), while A scores 77/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.
Is AbbVie Inc. in financial distress?▼
ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. A scores 5.2 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.
Which stock has higher return on invested capital, Agilent Technologies, Inc. or AbbVie Inc.?▼
ABBV earns 27.6% ROIC versus A's 12.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.
Which dividend is safer, Agilent Technologies, Inc.'s or AbbVie Inc.'s?▼
A's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). A has raised its dividend for 3 consecutive years.